Cite
HARVARD Citation
Furer, V. et al. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases. 80 (10), pp. 1330-1338. [Online].